跳转至内容
Merck
CN
  • Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.

Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.

Cell host & microbe (2019-02-24)
Carole Henry, Nai-Ying Zheng, Min Huang, Alexandra Cabanov, Karla Thatcher Rojas, Kaval Kaur, Sarah F Andrews, Anna-Karin E Palm, Yao-Qing Chen, Yang Li, Katerina Hoskova, Henry A Utset, Marcos C Vieira, Jens Wrammert, Rafi Ahmed, Jeanne Holden-Wiltse, David J Topham, John J Treanor, Hildegund C Ertl, Kenneth E Schmader, Sarah Cobey, Florian Krammer, Scott E Hensley, Harry Greenberg, Xiao-Song He, Patrick C Wilson
摘要

Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction of this population. A key aspect of antibody-mediated anti-influenza virus immunity is adaptation to antigenically distinct epitopes on emerging strains. We examined factors contributing to reduced influenza vaccine efficacy in the elderly and uncovered a dramatic reduction in the accumulation of de novo immunoglobulin gene somatic mutations upon vaccination. This reduction is associated with a significant decrease in the capacity of antibodies to target the viral glycoprotein, hemagglutinin (HA), and critical protective epitopes surrounding the HA receptor-binding domain. Immune escape by antigenic drift, in which viruses generate mutations in key antigenic epitopes, becomes highly exaggerated. Because of this reduced adaptability, most B cells activated in the elderly cohort target highly conserved but less potent epitopes. Given these findings, vaccines driving immunoglobulin gene somatic hypermutation should be a priority to protect elderly individuals.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
结晶紫溶液 溶液, 1%, aqueous solution